The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

Renee Gala named next CEO of Jazz Pharmaceuticals: Gala will take over as president and CEO on August 11, 2025, following ...

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

Life sciences marketing has long revolved around physicians. Traditionally seen as the gatekeepers of prescribing power, ...

ADRX-0405 is uniquely being tested during its 1a/b clinical trials. ADRX-0405 is labeled as a STEAP1 ADC (primarily ...

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...

In today’s fast-paced, innovation-fueled biopharma landscape, the traditional model of C-suite leadership is being turned on ...

Accelerated approval was based on results from the Phase I/II LINKER-MM1 trial, which showed a 70% objective response rate in ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...